Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Resmed (RSMDF) Receivables (2016 - 2025)

Historic Receivables for Resmed (RSMDF) over the last 16 years, with Q4 2025 value amounting to $1.0 billion.

  • Resmed's Receivables rose 1544.6% to $1.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year increase of 1544.6%. This contributed to the annual value of $990.7 million for FY2025, which is 1315.99% up from last year.
  • As of Q4 2025, Resmed's Receivables stood at $1.0 billion, which was up 1544.6% from $958.4 million recorded in Q3 2025.
  • In the past 5 years, Resmed's Receivables registered a high of $1.0 billion during Q4 2025, and its lowest value of $534.2 million during Q1 2022.
  • Over the past 5 years, Resmed's median Receivables value was $731.0 million (recorded in 2023), while the average stood at $756.9 million.
  • Per our database at Business Quant, Resmed's Receivables plummeted by 458.82% in 2021 and then soared by 3330.66% in 2023.
  • Over the past 5 years, Resmed's Receivables (Quarter) stood at $550.7 million in 2021, then increased by 26.27% to $695.4 million in 2022, then rose by 9.91% to $764.3 million in 2023, then increased by 18.66% to $907.0 million in 2024, then grew by 15.45% to $1.0 billion in 2025.
  • Its last three reported values are $1.0 billion in Q4 2025, $958.4 million for Q3 2025, and $990.7 million during Q2 2025.